Alexander D. Stein, MD
7204 Shoreline Drive, #160 Tel.: (718) 753-6536
San Diego, CA 92122 E-mail: [email protected]
PROFESSIONAL EXPERIENCE
02/2019 – present Stein Dermatology, A Professional Corporation Dermatology, Moh’s - Skin Surgery
Chula Vista, CA
05/2014 – present Advanced Dermatology Surgical and Medical Group Advanced Dermatology and Plastic Surgery
Mohs Surgeon Lakewood, CA
09/2015 – 01/2018 Center for Family Health Dermatologist
La Mesa CA 03/2016 – 06/2018 Khuu Dermatology
Mohs Surgeon and Dermatologist San Jose and Mountain View, CA 06/2016 – 09/2016 MedDerm Dermatology
Dermatologist and Mohs/skin Surgeon San Diego, CA
10/2015 – 06/2016 Advanced Dermatology and Cancer Specialists Dermatologist and Mohs Surgeon
Temecula, CA
04/2014 – 03/2016 Chaparral Medical Group
Dermatologist and Mohs Surgeon Upland, CA
08/2012 – 03/2014 Healthcare Partners Dermatology Dept.,
Attending Physician,
Skin and General Oncologist Washington Cancer Institute, Washington Hospital Center Washington, DC
Lombardi Cancer Center, Georgetown University Hospital Washington, DC
Assistant Professor of Medicine, Georgetown University,
Washington, DC
EDUCATION
07/2009 –06/2012 Residency in Dermatology
University of California at San Diego
Hillcrest Med Ctr, Thornton, VA La Jolla, Rady Children’s and the Naval Hospital (didactic activities) Hospitals
San Diego, US
07/2008 – 06/2009 Clinical Research Fellowship in Dermatology
University of California at San Diego Center for Innovative Therapies Dermatology Clinical Research Unit San Diego, US
08/2002 – 07/2005 Medical Oncology and Hematology Fellowship
New York Medical College,
Our Lady of Mercy Comprehensive Cancer Center New York, US
08/2001-07/2002 Chief Medical Resident (Internal Medicine)
New York Medical College, St. Vincent’s Med Center New York, US
08/2000 – 07/2002 Medical Residency (Internal Medicine)
New York Medical College, St. Vincent’s Medical Center
PGY2-PGY3 Internal Medicine Resident New York, US
07/1999-06/2000 Medical Internship (Internal Medicine)
New York Medical College,
Our Lady of Mercy University Medical Center New York, US
02/1996 – 06/1999 Medical Residency (Internal Medicine)
PGY2 - PGY5
University Hospital “N.Gh.Lupu”Colentina, “Carol Davila” University
Bucharest, Romania
02/1995 – 01/1996 Medical Internship (Internal Medicine)
PGY1
University Hospital “N.Gh.Lupu”Colentina, “Carol Davila”University
Bucharest, Romania
10/1988 – 09/1994 M.D., Medical School,
University of Medicine and Pharmacy “Carol Davila” Bucharest Bucharest, Romania -graduated top 1% with 9.81(out of 10) GPA
BOARD CERTIFICATION
07/2013 American Board of Dermatology (ABD) Board Certified in Dermatology
00/2005 American Board of Internal Medicine and Specialities (ABIM), Board Certified in Medical Oncology
00/2005 American Board of Internal Medicine and Specialities (ABIM), Board Certified in Hematology
00/2002 ABIM, Board Certified in Internal Medicine American Board of Internal Medicine Scored 10/10
PROFESSIONAL SOCIETIES (selected)
2009 – present Fellow, American Academy of Dermatology (AAD) 2013 – present American Society for Mohs Surgery (ASMS)
HONORS AND AWARDS
2001 American College of Physicians
Scored 98 percentile at PGY-3 level in the ACP In-Service Exam 2001-2002 Chief Medical Resident
New York Medical College, St.Vincents Med Center, New York
2002 Physician Recognition Award in CME
American Medical Association
2002 ABIM, Board Certified in Internal Medicine scored 10/10 decile
2004 Fellow Research Competition,1st place winner
New York Medical College, OLM Med Center, New York
2005 ECOG Young Investigator Awardee
East Cooperative Oncology Group
2005-2008 Associate Council
American Association for Cancer Research (AACR)
2010 UCSD Dermatology Research Competition 1st place winner
University of California at San Diego (UCSD), San Diego, California
PUBLICATIONS
Melanoma-Specific Marker Expression in Skin Biopsy Tissues as a Tool to Facilitate Melanoma Diagnosis. J Invest Dermatol. 2010 Apr 1. [Epub ahead of print] PubMed PMID: 20357814.
Malignant Melanoma in Pigmented Skin: Does the Current Interventional Model Fit a Different Clinical, Histological, and Molecular Entity? Dermatological Surgery 2014
IFN-Conditioned Dendritic Cells for the Therapy of Melanoma: What is Missing? J Immunother. 2011:6. New frontiers in laser surgery. Semin Cutan Med Surg. 2012 Jun;31(2):88-97.
A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. J Eur Acad Dermatol Venereol. 2013 May 3. doi: 10.1111/jdv.12176. Malignant melanoma in pigmented skin: does the current interventional model fit a different clinical, histologic, and molecular entity? Dermatol Surg. 2013 Sep;39(9):1291-303.
National and International Meetings Abstracts and Posters
Development of systemic neoplasias in family members of patients with cutaneous sarcoidosis. European Academy of Dermatology and Venerology October 7-10, 2009 Berlin.
Survival of Acral Melanoma in African American Patients after Surgical Excision. American Society for Mohs Surgery, Orlando 2011
Costs of Surgical Treatment of Melanoma. American Society for Mohs Surgery, Orlando 2011.
Development and Validation of a Chromogenic RNA In-Situ Hybridization Assay for Diagnosis of Atypical Melanocytic Nevi and Malignant Melanoma, abstract #932, United States & Canadian Academy of Pathology’s 102nd Annual Meeting, March 2-8, 2013, Baltimore, MD.
JOURNAL REVIEWER
2004- present Reviewer, Journal of the American Academy of Dermatology (JAAD) 2004- present Reviewer, British Journal of Dermatology
2004- present Reviewer, CED Clinical and Experimental Dermatology 2007- present Reviewer, Melanoma Research
RESEARCH
2013 –2014 Development and Validation of a Chromogenic RNA In-Situ Hybridization Assay for Diagnosis of Atypical Melanocytic Nevi and Malignant Melanoma
Advanced Cell Diagnostics, Inc. Hayward, CA
2010 - 2012 Novel RNA in situ hybridization technology for detection of mRNA in situ in formalin-fixed paraffin-embed tissue (RNAscope™).
Advanced Cell Diagnostics, San Francisco, CA
2004 - 2006 Phase I Study of Biochemotherapy for the Treatment of Metastatic Melanoma. PI, New York Medical College, OLMMC, New York
VOLUNTEER ACTIVITIES
08/2005-03/2006 New York Medical College, Our Lady of Mercy Med. Ctr. Clinical Research Associate, Investigated MVC chemotherapy in Hodgkin’s Disease; High-dose rituximab treatment – response and immunological reconstitution in CLL; Hemodynamic parameters of response in metastatic melanoma after treatment with high-dose interleukin-2.
04/2008 – 06/2008 Georgetown University, GU University Hospital, Department of Dermatology.Performed Volunteer research on skin cancers
PERSONAL
Former Speed Ice Skating Regional Champion. Enjoy Music, Art, Golfing.